Used as a key intermediate in the synthesis of peptide-based pharmaceuticals, particularly in the development of protease inhibitors. Its chiral center and protected amine group make it valuable in solid-phase peptide synthesis, where selective coupling and deprotection steps are required. The fluorenylmethyloxycarbonyl (Fmoc) group allows for mild base-labile protection, enabling stepwise assembly of complex peptides. The chloro-methoxyphenyl moiety provides structural specificity, often exploited in drugs targeting enzymes with aromatic binding pockets. Commonly applied in research settings for designing bioactive molecules, including antiviral and anticancer agents.